LB Pharmaceuticals Inc Common Stock LBRX Ratios & Valuation
| FY'25 | ||
|---|---|---|
| Returns | ||
| Return on assets | -14.5%— | |
| Liquidity | ||
| Current ratio | 41.4×+37.9× | |
| Quick ratio | 41.4×+37.9× | |
| Cash ratio | 33.6×+30.8× | |
| Leverage | ||
| Debt-to-equity | 0×— | |
| Debt-to-assets | 0×-0.1× | |
| Per Share | ||
| Book value per share | $37.45+114% | |
| Valuation | ||
| Market capitalization | $874.06M+163% | |
| Enterprise value | $556.86M— | |
| Price / book | 2.3×— | |
| Earnings yield | -4.4%— |
Questions, answered.
- Where do LB Pharmaceuticals Inc Common Stock's ratios come from?
- Every ratio is computed from LB Pharmaceuticals Inc Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.